[{"Assets_0_Q1_USD":1872198000.0,"CommonStockSharesOutstanding_0_Q1_shares":37802998.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":39448000.0,"NetIncomeLoss_1_Q1_USD":17403000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":12066000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":38813000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":37697000.0,"StockholdersEquity_0_Q1_USD":1109469000.0,"EarningsPerShareBasic_1_Q1_USD":0.46,"EarningsPerShareDiluted_1_Q1_USD":0.45,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":162970000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20180930","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20181107"}]